In a report released yesterday, Sheila Kahyaoglu from Jefferies maintained a Hold rating on Honeywell International (HON – Research Report), with a price target of $230.00. The company’s shares closed last Friday at $205.10.
According to TipRanks.com, Kahyaoglu is a 4-star analyst with an average return of 6.2% and a 55.7% success rate. Kahyaoglu covers the Technology sector, focusing on stocks such as Aerojet Rocketdyne Holdings, L3Harris Technologies, and Raytheon Technologies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Honeywell International with a $237.15 average price target, representing a 13.3% upside. In a report issued on January 14, Berenberg Bank also initiated coverage with a Hold rating on the stock with a $230.00 price target.
Honeywell International’s market cap is currently $141.2B and has a P/E ratio of 26.38.
Based on the recent corporate insider activity of 75 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HON in relation to earlier this year. Most recently, in October 2021, Robin Washington, a Director at HON bought 3,152 shares for a total of $223,477.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1885, North Carolina-based Honeywell International, Inc. is a technology and manufacturing company. It provides industry specific solutions including aerospace and automotive products and services; control technologies for buildings and homes; and performance materials. It operates through four segments, including Aerospace; Honeywell Building Technologies; Performance Materials and Technologies; and Safety and Productivity Solutions.
Read More on HON:
- New Buy Rating for Freeport-McMoRan (FCX), the Energy Giant
- Analysts’ Top Technology Picks: ServiceNow (NOW), Schrodinger (SDGR)
- Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), BridgeBio Pharma (BBIO) and Kinnate Biopharma (KNTE)
- IHS Markit Reports Strong Q4 Results
- Kraft Heinz Announces CFO Departure, Leadership Changes